The Effectiveness and Safety of Romosozumab and Teriparatide in Postmenopausal Women With Osteoporosis - Top-Institutions - MDSpire

The Effectiveness and Safety of Romosozumab and Teriparatide in Postmenopausal Women With Osteoporosis

  • By

  • Martin C Hartz

  • Fabian B Johannessen

  • Torben Harsløf

  • Bente L Langdahl

  • July 16, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Bone Metabolism

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Bone Biology
    • Clinical Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Clinical Trials

  • #4

    Aarhus University Hospital
    Aarhus University Hospital

    Aarhus, Denmark

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Clinical Research

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Clinical Trials

Original Source(s)

The Effectiveness and Safety of Romosozumab and Teriparatide in Postmenopausal Women With Osteoporosis

  • by Martin C Hartz, Fabian B Johannessen, Torben Harsløf, Bente L Langdahl

  • July 16, 2024

Related Content

Zoledronate Administration Lowers Vertebral Fracture Incidence in Younger Postmenopausal Women Lacking Osteoporosis

The role of gut microbiota in osteoporosis: underlying mechanisms, clinical associations, and emerging biomaterials

Radiomic Analysis Based on MRI Sequences for Identifying Spinal Bone Density Loss